Greetings!
The next time you buy something, think twice before holding the receipt generated on thermal paper. There is a high chance you may be exposing yourself to an endocrine disrupting chemical — Bisphenol-A (BPA). Read more on this hazardous hormone disrupting chemical that we, unknowingly, push into our system in our daily lives in our PSM India capsule and FAQ section.
There has been lots happening around the efficacy of drugs in our country lately. Be it the drugs body setting up a panel to review safety of FDCs or Health policy aiming at comprehensive healthcare for all; ensuring pharma cos do stability tests for all drugs or re-inspecting their manufacturing plants; corporate hospitals starting to report ADRs or monitoring retail drug supplies to patients; it’s all been covered in this issue of The Prescription. Hope you enjoy reading them as much as we did collating them for you.
Growth in the development of rare disease medicines has helped boost the number of new drugs approved in both the United States and the European Union. US saw a 21-year high of 46 new medicines being approved by the US Food and Drug Administration (FDA) in 2017, more than double the number approved the previous year. In the EU 92 new drugs were approved, up from 81 the year before. Our Global Injections carries more details on this while also including drug alerts and global acts and regulations on medicines.
Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@jagograhakjago.com
The request we made in our 1st January issue of The Prescription of each one touching 5 lives this year, including yourself, with your positive actions remains to be seen. Post your pics on our facebook wall or chirp it on our twitter handle. Go ahead and reach out.
Stay Healthy. Stay Protected.
Pooja Khaitan
Editor-in-Chief,
The Prescription
“Universal Health Coverage will never be achieved in India till the Government spends Rs 8 lac Crores per year dedicatedly used for a robust healthcare system in India. Patience, Perseverance and Passion is needed by the government to provide effective healthcare to us Indians. It’s time to Walk the Talk.”
Mr. Anil KhaitanPresident, PHD Chamber of Commerce and Industry
Over 92% People Don't Trust Healthcare System In India: A Report
Have you ever doubted your doctor’s decision? If so, you are not the only one.This is a warning sign. If there is no trust between patients and physicians the positive outcomes of care are highly questionable. As per the GOQii India Fit 2018 report, 92.3% of citizens do not trust the healthcare system in India, which includes doctors, hospitals, pharma, insurance companies and diagnostic labs.The survey claims to have used inputs from about 2 lakh GoQii product users in the country. As per the survey, 74 per cent people said that they do not trust hospitals, followed by pharma and insurance firms (62.8 per cent), medical clinics (52.6 per cent), 50.6 per cent doctors and diagnostic labs (46.1 per cent).
The next time you buy something, think twice before holding the receipt generated on thermal paper. There is a high chance you may be exposing yourself to an endocrine disrupting chemical — Bisphenol-A (BPA). A study conducted by environmental NGO Toxics Link states that thermal paper — which is commonly used in receipts at grocery stores, gas stations and ATMs — has been found with high BPA content across markets in Delhi.
The combined sales of all 10 drugs on GEN’s list from January through September of 2017 was $39.632 billion, up 15.2% from $34.407 billion in Q1–Q3 2016. While cancers are among the deadliest of diseases, only one category ranks within the World Health Organization’s list of Top 10 Causes of Death
Amantadine Now Available To Treat Parkinson Disease Dyskinesia
Maryland, 11 Jan 2018: Adamas announced the availability of Gocovri (amantadine) extended-release capsules for the treatment of dyskinesia in patients with Parkinson disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications.
US FDA Acts To Protect Kids From Serious Risks Of Opioid Ingredients
Maryland, 11 Jan 2018: The U.S. Food and Drug Administration announced today that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years old because the serious risks of these medicines outweigh their potential benefits in this population.
No Changes To UK Drug Regulations After Brexit
London, 18 Jan 2018: The UK’s drugs regulator has reiterated its promise to minimise disruption caused by a potential hard Brexit, telling pharma companies that there will be no sudden changes to the country's regulatory framework when it leaves the EU in March 2019.
INTERDICT Act Gives CBP $9 Million To Spend On Technology To Detect Fentanyl
January 19, 2018: As reported by the Washington Post and USA Today, the recently signed into law INTERDICT Act, an acronym for International Narcotics Trafficking Emergency Response by Detecting Incoming Contraband with Technology, gives U.S. Customs and Border Patrol (CBP) $9 million to increase staff and purchase equipment to detect fentanyl and other opioids at border crossings and mail facilities.
Counterfeit Pills Laced With Fentanyl Are Ravaging Communities Across North America
For more than a decade, counterfeit drugs with unreliable ingredients have caused patients suffering by not curing their illnesses. Now, counterfeit drugs with deadly ingredients threaten American lives with just one dose. A closed, secure supply chain is even more imperative when the risk of breakage is death.
Frequently Asked Questions Q1. What is Endocrine Disruption? How do they affect Us? How can we reduce exposure To Hormone-Disrupting Chemicals?
Answer: What keeps you up at night? Sick kids, restless pets, the latest tragedy on the evening news, politics, wars, earthquakes, hurricanes, fires, money troubles, job stress, and family health and wellbeing? There is no shortage of concerns that make us all toss and turn.
But what keeps the chemical industry up at night? A couple of decades ago a senior Shell executive was asked this very question. The answer? Endocrine disruption. If you can even pronounce “endocrine disruption,” you’re doing well. What is it? Why should we care? And why is it keeping chemical bigshots up at night? Read More>>>
What supplements do scientists use, and why?
Article contributed by our subscriber, Prof.V.K.Shastri, Madhya Pradesh
Supplements are a strange thing. Although they’re a multi-billion industry, producers don’t need to prove that they are effective — only that they are safe. As a result, among the evidence-based products, a lot of snake-oil has also snuck on the shelves.
Ms. Priya Rai, Academician blogs:Patients need to become aware and fight for their rights in every cases of negligence and misbehavior. PSM India has already shown the path and we should strive to follow it!
Dr. Neha Jaiswal, Physician says: Thanks PSM India for all such recent news articles! The Prescription help us to stay informed and updated.
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.